Celldex says barzolvolimab hit all primary and secondary goals in two Phase 3 CSU trialsSep 22Clinical readoutbarzolvolimabCelldex Therapeutics
Celldex reports Q2 2026 results as barzolvolimab Phase 3 enrollment finishes earlyAug 6Quarterly updatebarzolvolimabCelldex Therapeutics
Sign inSign in